Most disease research reports suggest that delayed diagnoses are one of the leading causes of increased disease burden in developing nations
Read More
Established in 2011 as a 50:50 joint venture for pharmaceutical sales and marketing in India, Bayer has now acquired the remaining 25 per cent stake to secure full ownership of the entity, in accordance with pre-agreed joint venture terms
Read More
